Skip to main content
. 2022 Mar 2;9:846282. doi: 10.3389/fnut.2022.846282

FIGURE 1.

FIGURE 1

Experimental scheme. The evaluation of the potential of PS-Zein-CUR an oral agent for CRC therapy: physicochemical properties, anti-CRC effects, cellular uptake, and gastrointestinal simulated digestion in vitro and pharmacokinetics and tissue distribution in vivo.